Data Related Content
Why is data so critical to decarbonisation?
Matthew Roderick, CEO of n3rgy, explains why smart meters and the data within them are key to controlling and storing green renewable energy.
The real threat of working from home
Here, IT Naturally discuss how the rise of working from home has lead to a rise in cybercrime risk and how we can combat this.
AstraZeneca vaccines made for UK could be kept for EU use only
EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.
Taiwan: High-resolution seabed geophysical survey research
Gwo-shyh Song, Associate Professor at the National Taiwan University and Global Aqua Survey Ltd, walks us through his high-resolution seabed geophysical survey research around offshore areas in Taiwan.
The unsolvability of the mind-body problem enables free will
Jan Scheffel, Professor from KTH Royal Institute of Technology, Sweden, argues that the insolvability of the mind-body problem enables free will.
How scientific networks bring cutting-edge science upfront
When it comes to developing functional ideas for climate, scientific networks are crucial for bringing cutting-edge science upfront.
Scientists reveal that tinnitus is possible COVID-19 symptom
The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.
European Commission launches process on dataflows to UK
Logan Finucan, Access Partnership, explains how the European Commission has launched the process towards the adoption of two adequacy decisions for personal dataflows to the UK.
US trial finds AstraZeneca vaccine 100% effective against COVID death
In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.
Digital Asset Management Solutions within the NHS and the Public Sector
Chris Haden, CEO of Engeneum Limited, tells us about an NHS Trust and a Local Authority where Engeneum’s Digital Asset Management Solution is used to improve efficiency and support homeworking.
How will the Census improve policy decisions to address the post-COVID economy?
Adam Mayer, Senior Manager at Qlik, discusses why the 2021 Census will underpin better policy decisions to address the post-COVID economy.
Poll finds 61% of people in France think AstraZeneca vaccine is unsafe
According to a new YouGov poll, 61% of people in France now believe that the AstraZeneca vaccine is unsafe, with Germany following closely at 55% - creating fears about the potential impact of vaccine hesitancy on the rollout.
Research finds anti-Asian racism rose after COVID-19 called “China Virus”
The recent shootings in Atlanta and Cherokee County took eight lives, six of them Asian - highlighting the rise in anti-Asian racism after COVID-19.
Using customer centric service design to improve public sector services
"Let's build solutions that enable a vision for future generations and to show the world how great the UK is in providing outstanding customer service", says Simon Seymour-Perry, Country Managing Partner at Netcompany.
Vaccine shortage in UK means under-50s to wait longer for first dose
The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.
Digital solutions to reduce household carbon footprint
Gavin Ellis, Director and Co-Founder of Hubbub, discusses how digital solutions can be used to help households reduce their carbon footprint and save money.
Diphtheria slowly becomes resistant to antimicrobial treatment
There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.
Novavax 96.4% effective against the original COVID mutation
The US based vaccine appears to be 96.4% effective against the original COVID mutation, with 86% efficacy against the UK variant and only 55% against the South African variant.
How OPEX is providing digitisation solutions for the NHS
Here, we learn how solutions-based organisation OPEX are simplifying the often daunting and complex digitisation process of healthcare records to vastly benefit the NHS.
How regulatory technology delivers compliance ROI
Vivek Dodd, co-founder of Skillcast, discusses how regulatory technology (RegTech) can help businesses avoid fines, breaches, reduce costs and deliver Return on Investment (ROI).